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ORIGINAL ARTICLE
Adrenal haemorrhage in term neonates: a retrospective study
from the period 2001–2013
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1Department of Obstetrics and Gynaecology and 2Department of Paediatrics, University of Szeged, Szeged, Hungary
Abstract
Objective: To assess the incidence, risk factors and clinical presentations of neonatal adrenal
haemorrhage (NAH) in uncomplicated, singleton and term deliveries.
Methods: A retrospective analysis of 26 416 term neonates delivered between 2001 and 2013,
and screened with abdominal ultrasonography.
Results: Of the 26 416 neonates, 74 (0.28%) displayed NAH; the male/female ratio was 1.55:1.
Vaginal delivery was significantly more frequent than caesarean section among them (71 versus
3; 95.9% versus 4.1%). Unilateral bleeding occurred on the right side in 36 (48.7%), and on the
left in 34 (45.9%), without a significant difference; bilateral haematomas were found in four
cases (5.4%). The most common risk factors were macrosomia (16, 21.6%) and fetal acidaemia
(23, 31%), while four (5.4%) neonates exhibited pathological acidaemia. Clinical presentations
included jaundice in 37 (50%), anaemia in six (8.1%) and an adrenal insufficiency in only one
(1.3%) case. In three cases, neuroblastoma was diagnosed.
Conclusions: Vaginal delivery, macrosomia and fetal acidaemia are the most important risk
factors for NAH. The adrenal glands on both sides were similarly involved. In the healthy
neonates with NAH, the clinical presentations were mild, with spontaneous regression.
Differentiation of NAH from tumours is of considerable importance.
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Introduction
Adrenal bleeding in the perinatal period may remain asymp-
tomatic and, as routine neonatal abdominal screening is not
common practice worldwide, its exact incidence cannot be
determined. Earlier estimates indicated 1.7–2.1 per 1000
births, depending on the mode of diagnosis, which in most
cases is ultrasonographic (USG) screening [1]. The patho-
genesis is still unclear; the extensive vascularity and the
relatively large size enhance the vulnerability of the adrenal
glands to venous pressure changes, and mechanical compres-
sion also has a role during delivery [2]. Predisposing factors
include prematurity, prolonged labour, a difficult delivery,
macrosomia, perinatal hypoxia, coagulation disorders and
septicaemia, though in most cases the aetiology cannot be
established [3]. Neonatal adrenal haemorrhage (NAH) can
occur in utero, but it usually appears perinatally; 5–10% of the
cases involve bilateral haemorrhage; interestingly, in the
unilateral cases, right adrenal gland involvement has been
reported more frequently [4]. The clinical features are
variable: anaemia, persistent indirect hyperbilirubinaemia,
abdominal distension with an abdominal mass, and a bluish
discolouration of the scrotum [5]. Whereas minor bleeding
into the adrenal cortex may remain asymptomatic, a severe
blood loss can be life-threatening, with hypovolaemic shock
or an adrenal insufficiency. The differential diagnosis of
suprarenal masses should include neuroblastoma, the pre-
dominant neonatal malignancy, teratomas, subdiaphragmatic
extralobar pulmonary sequestration, vascular thrombosis and
congenital adrenal cystic lesions [6].
In this study, we set out to review the incidence, risk
factors and clinical presentations of NAH in term infants in
our neonatal department over a 13-year period.
Methods
This was a retrospective study on singleton pregnancies of
women who delivered at the Department of Obstetrics and
Gynaecology, University of Szeged, Hungary, between
01.01.2001 and 31.12.2013. The inclusion criteria included
a gestational age at delivery of at least 37 completed weeks;
26 416 full-term mature neonates of either sex, born between
gestational weeks 37 and 41, were enrolled. Neonates who
needed neonatal intensive care immediately after birth were
not included in the study. The maternal data, gestational age,
parity, mode of delivery and the presence of gestational
diabetes mellitus were reviewed.
Every baby had ultrasound examination on day 2 of their
life; this practice was adapted to screen renal abnormalities.
Address for correspondence: Zita Gyurkovits, Department of Obstetrics
and Gynaecology, University of Szeged, Semmelweis Street 1, 6725
Szeged, Hungary. Tel: +36 70 4083878. Fax: +36 62 545711. E-mail:
gyurkovits2000@yahoo.com
Considering that our university is a tertier center with a
numerous transfers from other regions without proper ante-
natal care, our department decided to introduce renal
screening. The significance of renal screening is well-
known in the literature, where sonographic screening of the
kidneys and the urinary tract was described as a very effective
and non-invasive screening method after birth. It allows
planning for appropriate diagnostic tests and therapeutic
procedures in a timely fashion [7–9].
Suprarenal masses were diagnosed via postnatal USG of
the abdomen on the second day of postnatal life, and the site
of adrenal haemorrhage was recorded.
From the data in the files on the neonates, we analysed the
presence of risk factors and comorbidities, such as a high
birthweight, fracture of the clavicle, cephalhaematoma,
anaemia, hyperbilirubinaemia, hypoglycaemia and respiratory
disorders. The neonatal outcome was investigated from the
aspects of the umbilical cord blood pH, the base excess (BE)
and the 5–10 min Apgar scores. The neonatal outcomes were
compared between two groups: the neonates with NAH and
the control group, 5167 consecutive healthy term neonates
born in a 2-year period (2012 and 2013). We found that this
approach is statistically proper and allows a sufficiently
correct and relevant basis of reference as a control group for
comparison with the NAH group.
Immediately after delivery, a segment of the umbilical cord
was double-clamped, and blood was drawn from the artery
into preheparinized plastic syringes. Coagulation was inhib-
ited with EDTA. The whole-blood samples were analysed
within 5 min of collection for pH and BE. Acidaemia was
defined as an umbilical blood pH57.2 or/and an umbilical
BE 512 mmol/l (a BE of 12 mmol/l is approximately
2SDs below the mean), and pathological fetal acidaemia was
diagnosed when the umbilical blood pH was57.0. Maternal
acidaemia as a cause of the cord blood acidaemia was
excluded.
Macrosomia was defined as a birthweight44000 g, and
anaemia as a haemoglobin level more than 2SDs below the
mean value for the corresponding age [10]. The definition of
hypoglycaemia was a blood glucose level 52.6 mmol/l.
Hyperbilirubinaemia was defined according to the Clinical
Practice Guideline of the American Academy of Paediatrics
published in 2004 [11].
Statistical analysis was performed by using the chi-square
test; a level p50.05 was considered to be statistically
significant.
Results
Abdominal USG was applied in the total of 26 416 singleton
neonates included in the study from the 13-year period; 74 of
the neonates demonstrated NAH, an incidence of 0.28%.
The vast majority, 71 (95.9%) of these 74 neonates, were
delivered by vaginal delivery, and only 3 (4.1%) by
caesarean section; the frequency of caesarean section in the
NAH group was significantly lower than that in the control
group (40.6%).
The haemorrhagic lesions were evaluated by USG as
inhomogeneous lesions with decreased echogenicity that were
mixed solid-liquid or echogenic masses.
NAH was more frequent in boys (60.8%) than in girls
(39.2%); the difference was significant. Thirty six neonates
(48.7%) had a unilateral haematoma on the right side, while
34 (45.9%) had one on the left, with no significant difference
between the sides. Bilateral haematomas were found in four
cases (5.4%).
The mean birthweight and gestational age were
3640 ± 424 g and 39.1 ± 1.0 weeks, respectively; 29 (39%)
of the 74 were primipara and 45(61%) were multipara.
Sixteen (21.6%) of the 74 neonates were macrosomic, i.e. a
significantly higher proportion as compared with the macro-
somic neonate rate (7.1%) for the entire population at our
department. Four mothers (5.4%) were diagnosed with
gestational diabetes mellitus, a similar level of incidence as
in our previous data.
As concerns the general condition at birth of the neonates
with NAH, in 23 (31%) the umbilical cord blood pH was
57.2, or/and had BE 512 mmol/l; fetal acidaemia was
therefore significantly more frequent in the NAH group. Four
(5.4%) of the 23 displayed pathological acidaemia with
an umbilical cord blood pH57.0. Five neonates (6.7%) had a
5- or 10-min Apgar score57 (p50.05).
The most common significant clinical features in the
neonates with NAH were indirect hyperbilirubinaemia, in 37
(50.0%) cases, and anaemia in six (8.1%) cases (p50.001).
Other clinical presentations included birth trauma, e.g.
cephalhaematoma (5; 6.7%); as compared with the controls,
this was very close to the limit of significance. In cases of
clavicle fracture (1; 1.3%) and hypoglycaemia (2; 2.7%),
significance calculations could not be carried out, because of
the low incidence, but both clinical presentations were
observed with similar incidence in the NAH and control
groups.
We have not found any abnormal palpable masses among
these 74 babies although all the newborns were examined at
least two times by specialised neonatologists. There was no
significant difference in the rates of respiratory disorders
between the NAH and control group (8.1% versus 6.3%).
Table 1 summarises the statistical data and an analysis of
the NAH and control groups. No perinatal mortality occurred
in either study group.
One neonate (1.3%) with bilateral NAH developed an
adrenal insufficiency and was treated with glucocorticoid.
Coagulation disorder and sepsis were not observed. The mean
time for complete resolution of the haemorrhage was 18 ± 8
weeks. Three of the suprarenal masses proved to be congeni-
tal neuroblastomas (as confirmed by colour Doppler USG and
pathological analysis) developing from the adrenal glands;
these neonates were transferred and treated in another unit.
Discussion
This is the largest retrospective study that we are aware of
which reports on the prevalence of NAH among term
neonates. During a 13-year period, 74 neonates were
diagnosed with NAH by abdominal USG, reflecting an
incidence of 0.28% among the healthy term infants. Previous
studies have indicated a wide range of incidence, from 0.003%
up to 0.55%, depending on whether the selected population
was symptom-free or treated in an intensive care unit [12,13]
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and also on whether the mode of diagnosis was USG, CT or
autopsy.
Most of the neonates with NAH in our study were
delivered by vaginal delivery, which is consistent with earlier
findings and reflects the possible role of mechanical
compression and also a hypoxic-ischaemic event with subse-
quent reperfusion injury during vaginal delivery [14].
Although the precise mechanisms leading to adrenal haem-
orrhage are still unclear, the available evidences have
implicated the role of adrenocorticotropic hormone
(ACTH), adrenal vein spasm and thrombosis, the limited
venous drainage in the pathogenesis of this condition. The
adrenal gland has a rich arterial supply, in contrast to its
limited venous drainage, which is critically dependent on a
single vein. Furthermore, in stressful situations, ACTH
secretion increases, which stimulates adrenal arterial blood
flow and cause adrenal vein spasm so the limited venous
drainage capacity may cause venous stasis and may lead to
haemorrhage [10].
The occurrence of NAH was particularly high in the
macrosomic group and in those with fetal acidaemia or birth
asphyxia, which is again consistent with other reports in the
literature [15]. Furthermore, the common clinical presenta-
tions were similar to those in previous reviews, i.e. anaemia
and persistent indirect bilirubinaemia [16].
On the other hand, our study revealed that the right and left
sides were equally likely to be involved, in contrast with
former reports suggesting that the probability of right adrenal
gland haemorrhage involvement was higher. The mechanism
for a right-sided predilection is presumed to be the compres-
sion of the adrenal gland between the liver and the spine and
the pressure fluctuation in the inferior vena cava, which is
directly connected to the right adrenal gland. However, at our
department each infant undergoes abdominal USG screening.
This therefore furnished reliable data on a high number of
neonates, clearly demonstrating the equal likelihood of left
and right NAH.
It is noteworthy that the incidence of NAH exhibited a
slightly increasing tendency during this 13-year period,
despite the continuously falling rate of vaginal delivery in
our department.
This phenomenon may be explained in part by the rising
frequency of macrosomic neonates. During the last 2–3
decades an overall increase in the proportion of macrosomic
newborns has been found. The causes of the increasing
prevalence of large newborns are complex and insufficiently
explained, however this is a common phenomenon in many
developed countries. The incidence of macrosomia varies
between 5% and 20%, the highest ratio is found in the Nordic
countries [17]. In Hungary, the incidences of macrosomia
(birthweight 44000 g) in the recent decades are shown
in Figure 1.
A number of risk factors for fetal macrosomia have been
recognised, the strongest is the gestational maternal diabetes.
Other modifiable risk factors are maternal pre-gestational
anthropometric characteristics, like BMI, excessive weight
gain during pregnancy, nutritional intake, level of physical
activity, smoking and metabolic parameters. Non-modifiable
factors include genes, fetal sex, parity, maternal age and
height [18,19].
In the event of a suprarenal mass, it is of the highest
importance to differentiate bleeding from a malignancy, such
as a neuroblastoma, which originates from the neural tube
cells. The tumour can be differentiated by the presence of
vascular flow with colour Doppler USG or CT and via the
catecholamine metabolite levels in the urine in the case of a
neuroblastoma. While conservative therapy is appropriate for
NAH, adrenal tumours may need surgical excision. An
adrenal mass can be followed up for one month with serial
USG without any adverse effects on the therapy and prognosis
of the tumour [20], persistence or enlargement suggesting an
adrenal neoplasm. We diagnosed three cases of neuroblast-
oma; at the time of detection, all of them were symptom-free,
the early diagnosis therefore was promoting a good prognosis.
NAH, and particularly the bilateral form, needs a careful
follow-up to prevent the later consequences, including
prolonged jaundice, anaemia or an adrenal insufficiency. In
our study, jaundice was observed in 50% and anaemia in 8.1%
of the NAH cases; they required only conservative treatment.
An adrenal insufficiency was diagnosed in only one patient,
who needed adequate hormone supplementation.
The limitation of our study is its retrospective nature,
which is why the exact descriptions of haemorrhages were not
recorded. Although an adrenal insufficiency is more frequent
among preterms than among mature neonates [21], preterms
were not included in the study as they were transferred to
Table 1. Outcome measures of neonates with NAH and the control group.
Comorbidities NAH (n¼ 74) Control (n¼ 5167) p
Males 45 (60.8%) 2602 (50.3%) 50.05*
Caesarean section 3 (4.1%) 2100 (40.6%) 50.001*
Vaginal delivery 71 (95.9%) 2955 (57.2%) 50.001*
Umbilical cord pH57.2 23 (31%) 775 (15%) 50.001*
Apgar score57 at 5 min 5 (6.7%) 93 (1.8%) 50.05*
Macrosomia 16 (21.6%) 366 (7.1%) 50.001*
Anaemia 6 (8.1%) 87 (1.7%) 50.001*
Indirect hyperbilirubinaemia 37 (50%) 1522 (29.4%) 50.001*
Cephalhaematoma 5 (6.7%) 150 (2.9%) 0.052
Clavicle fracture 1 (1.3%) 50 (1.0%) –
Hypoglycaemia 2 (2.7%) 163 (3.1%) –
Respiratory disorder 6 (8.1%) 326 (6.3%) 0.52
Significance at p50.05 is indicated by*.
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another department. Due to the same reason, the medical
follow-up of the neonates with an adrenal insufficiency or
neuroblastoma was not feasible.
Primary coagulation disorders and sepsis are also well-
known risk factors for bleeding, but they did not play a role in
the aetiology in our work.
In conclusion, this is the largest series of scanning for
NAH in healthy neonates that has been reported so far. The
findings highlight the diverse and non-specific clinical
presentation of NAH, though most of the cases had merely
mild consequences and needed only conservative treatment.
We still continue our screening protocol regarding abdom-
inal ultrasound screening for every term neonate, as benefits
overweigh the harms, according to our opinion. Particularly,
the follow-up of the newborns with any congenital abnorm-
alities became much more effective and precise with this
protocol. However, as further data and investigations are still
needed to clarify the presence and importance of the later
consequences, for other neonatal units we only recommend
abdominal ultrasound screening in the risk groups, like
macrosomic neonates with vaginal delivery or fetal acidae-
mia. A long term follow-up for the consequences of adrenal
haemorrhage is still needed. The importance of abdominal
USG screening is to be stressed, especially for vaginally
delivered macrosomic neonates, for those with fetal acid-
aemia and for newborns suffering from birth trauma, unex-
plained anaemia and prolonged icterus.
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Figure 1. Incidence of macrosomia
(birthweight44000 g) in Hungary from
1970 until 2010.
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